Shortages of crucial cancer medications continue to impact US healthcare
Today, the National Comprehensive Cancer Network® (NCCN®)-an alliance of leading cancer centers-published updated data on the current impact…
Aging brain actively shapes biology and progression of tumors
Brain tumors develop within an organ that changes substantially with age. A new review in Ageing and Cancer…
Kura Oncology launches diabetes-focused Caspian Therapeutics
Just under a year after netting its first US approval for a cancer-fighting menin inhibitor, Kura Oncology…
New prostate cancer screening advances improve early detection
Did you know that about 1 in 8 men will be diagnosed with prostate cancer during their lifetime?…
Federal and industry sponsors play complementary roles in cancer clinical trials
A comparative study of the cancer clinical trial portfolios supported by federal funding versus industry funding reveals they…
Scallop-derived plasmalogens may support brain health and memory
The study, funded by B&S Corporation Co., Ltd., which manufactures and markets scallop plasmalogen, evaluated memory and brain…
New Drug Turns Cancer’s Favorite Fuel Into a Deadly Weakness
Microscope image of hepatocellular carcinoma, the most common form of cancer to arise in the liver. Credit: University…
Circadian Oncology: Timing, Cancer Treatment, and Patient Outcomes
IntroductionCircadian regulation in cancer biologyThe promise and challenges of cancer chronotherapyThe future of circadian medicine in cancer careReferencesFurther…
New drug delivers promising survival gains in pancreatic cancer
About 90% of people with pancreatic cancer have pancreatic ductal adenocarcinoma (PDAC), which is driven by an activating mutation in…
Insilico Medicine highlights AI-powered biological target discovery for rare sinonasal cancer
Insilico Medicine (“Insilico”), a clinical-stage generative artificial intelligence (AI)-driven biotechnology company, today announced the publication of a collaborative…
Dual immunotherapy with neoadjuvant chemotherapy shows encouraging activity in ERBB2-negative breast cancer
A combination of two immunotherapy drugs showed encouraging activity when added to standard chemotherapy given prior to surgery…
Effects of CYP3A4, CYP3A5, and ABCB1 genetic variants on tacrolimus metabolism during the early period after kidney transplantation
Gupta R, Woo K, Yi JA. Epidemiology of end-stage kidney disease. Semin Vasc Surg. 2021;34:71–78. https://doi.org/10.1053/j.semvascsurg.2021.02.010 Article PubMed …